Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infections
Open Access
- 10 November 2022
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 7 (1) , 1-12
Abstract
Whole cell vaccines are complex mixtures of antigens, immunogens, and sometimes adjuvants that can trigger potent and protective immune responses. In some instances, such as whole cell Bordetella pertussis vaccination, the immune response to vaccination extends beyond the pathogen the vaccine was intended for and contributes to protection against other clinically significant pathogens. In this study, we describe how B. pertussis whole cell vaccination protects mice against acute pneumonia caused by Pseudomonas aeruginosa. Using ELISA and western blot, we identified that B. pertussis whole cell vaccination induces production of antibodies that bind to lab-adapted and clinical strains of P. aeruginosa, regardless of immunization route or adjuvant used. The cross-reactive antigens were identified using immunoprecipitation, mass spectrometry, and subsequent immunoblotting. We determined that B. pertussis GroEL and OmpA present in the B. pertussis whole cell vaccine led to production of antibodies against P. aeruginosa GroEL and OprF, respectively. Finally, we showed that recombinant B. pertussis OmpA was sufficient to induce protection against P. aeruginosa acute murine pneumonia. This study highlights the potential for use of B. pertussis OmpA as a vaccine antigen for prevention of P. aeruginosa infection, and the potential of broadly protective antigens for vaccine development.Keywords
Funding Information
- Cystic Fibrosis Foundation (BARBIE18G0)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI14167101A1, 5R01AI13715503)
- West Virginia University (WVU) Vaccine Development Center WVU institutional startup support
- West Virginia Space Grant Consortium
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM133369)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- Division of Science and Research, WV Higher Education Policy Commission
This publication has 76 references indexed in Scilit:
- Sequence-Verified Two-Allele Transposon Mutant Library for Pseudomonas aeruginosa PAO1Journal of Bacteriology, 2012
- Localization of GroEL determined by in vivo incorporation of a fluorescent amino acidBioorganic & Medicinal Chemistry Letters, 2011
- Full Virulence of Pseudomonas aeruginosa Requires OprFInfection and Immunity, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionJournal of Experimental Medicine, 2011
- Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virusProceedings of the National Academy of Sciences, 2010
- Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epitheliaMicrobiology, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Characterization of the outer membrane protein OprF of Pseudomonas aeruginosa in a lipopolysaccharide membrane by computer simulationProteins: Structure, Function, and Bioinformatics, 2008
- In-gel digestion for mass spectrometric characterization of proteins and proteomesNature Protocols, 2006
- The Protein Data BankNucleic Acids Research, 2000